Life sciences venture capital company Sofinnova has doubled down on its strategy to expand into digital medicine, closing its first dedicated fund for the category with $2
Life sciences venture capital company Sofinnova has launched a new strategy in digital medicine, accompanied by a series of investments in start-ups operating within the c